APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acquired Immunodeficiency Syndrome

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Acquired Immunodeficiency Syndrome Industry Growth and Trends Forecast to 2032

29 December 2025103 pages

Choose your research edition.

Industry ResearchAcquired Immunodeficiency Syndrome Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acquired Immunodeficiency Syndrome Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Acquired Immunodeficiency Syndrome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acquired Immunodeficiency Syndrome Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Acquired Immunodeficiency Syndrome Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Acquired Immunodeficiency Syndrome market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Acquired Immunodeficiency Syndrome market include Takeda, Sanofi, Novartis, Pfizer, Amgen, Merck KGaA, Daiichi Sankyo Company, Biogen and AstraZeneca Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acquired Immunodeficiency Syndrome market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acquired Immunodeficiency Syndrome market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acquired Immunodeficiency Syndrome market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acquired Immunodeficiency Syndrome.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Acquired Immunodeficiency Syndrome market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acquired Immunodeficiency Syndrome Market by Company

Takeda

Sanofi

Novartis

Pfizer

Amgen

Merck KGaA

Daiichi Sankyo Company

Biogen

AstraZeneca Eli Lilly and Company

Actelion

Acquired Immunodeficiency Syndrome Segment by Type

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Acquired Immunodeficiency Syndrome Segment by Application

Hospital Pharmacy

Retail Pharmacy

Others

Acquired Immunodeficiency Syndrome Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acquired Immunodeficiency Syndrome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acquired Immunodeficiency Syndrome and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acquired Immunodeficiency Syndrome.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Acquired Immunodeficiency Syndrome companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Acquired Immunodeficiency Syndrome Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Acquired Immunodeficiency Syndrome Market Share by Region (2021-2026) Table 4. Global Acquired Immunodeficiency Syndrome Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Acquired Immunodeficiency Syndrome Market Share by Region (2027-2032) Table 6. Global Acquired Immunodeficiency Syndrome Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2026) Table 9. Global Acquired Immunodeficiency Syndrome Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Acquired Immunodeficiency Syndrome Market Size Share Forecasted by Type (2027-2032) Table 11. North America Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Acquired Immunodeficiency Syndrome Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2026) Table 24. Global Acquired Immunodeficiency Syndrome Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Acquired Immunodeficiency Syndrome Market Size Share Forecasted by Application (2027-2032) Table 26. North America Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Acquired Immunodeficiency Syndrome Industry Trends Table 37. Acquired Immunodeficiency Syndrome Industry Drivers Table 38. Acquired Immunodeficiency Syndrome Industry Opportunities and Challenges Table 39. Acquired Immunodeficiency Syndrome Industry Restraints Table 40. Global Acquired Immunodeficiency Syndrome Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Company (2021-2026) Table 42. Global Acquired Immunodeficiency Syndrome Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Acquired Immunodeficiency Syndrome Key Company Headquarters & Area Served Table 44. Global Acquired Immunodeficiency Syndrome Company, Product Type & Application Table 45. Global Acquired Immunodeficiency Syndrome Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Acquired Immunodeficiency Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Acquired Immunodeficiency Syndrome Product Portfolio Table 52. Takeda Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Acquired Immunodeficiency Syndrome Product Portfolio Table 57. Sanofi Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Acquired Immunodeficiency Syndrome Product Portfolio Table 62. Novartis Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Acquired Immunodeficiency Syndrome Product Portfolio Table 67. Pfizer Recent Development Table 68. Amgen Company Information Table 69. Amgen Business Overview Table 70. Amgen Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Amgen Acquired Immunodeficiency Syndrome Product Portfolio Table 72. Amgen Recent Development Table 73. Merck KGaA Company Information Table 74. Merck KGaA Business Overview Table 75. Merck KGaA Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck KGaA Acquired Immunodeficiency Syndrome Product Portfolio Table 77. Merck KGaA Recent Development Table 78. Daiichi Sankyo Company Company Information Table 79. Daiichi Sankyo Company Business Overview Table 80. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Portfolio Table 82. Daiichi Sankyo Company Recent Development Table 83. Biogen Company Information Table 84. Biogen Business Overview Table 85. Biogen Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biogen Acquired Immunodeficiency Syndrome Product Portfolio Table 87. Biogen Recent Development Table 88. AstraZeneca Eli Lilly and Company Company Information Table 89. AstraZeneca Eli Lilly and Company Business Overview Table 90. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Portfolio Table 92. AstraZeneca Eli Lilly and Company Recent Development Table 93. Actelion Company Information Table 94. Actelion Business Overview Table 95. Actelion Acquired Immunodeficiency Syndrome Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Actelion Acquired Immunodeficiency Syndrome Product Portfolio Table 97. Actelion Recent Development Table 98. North America Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Acquired Immunodeficiency Syndrome Market Share by Country (2021-2026) Table 101. North America Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Acquired Immunodeficiency Syndrome Market Share Forecast by Country (2027-2032) Table 103. Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Acquired Immunodeficiency Syndrome Market Share by Country (2021-2026) Table 106. Europe Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Acquired Immunodeficiency Syndrome Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Country (2021-2026) Table 111. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share Forecast by Country (2027-2032) Table 113. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Acquired Immunodeficiency Syndrome Market Share by Country (2021-2026) Table 116. Latin America Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Acquired Immunodeficiency Syndrome Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2021-2026) Table 121. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Acquired Immunodeficiency Syndrome Product Image Figure 3. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 5. Global Acquired Immunodeficiency Syndrome Market Share by Region: 2025 VS 2032 Figure 6. Global Acquired Immunodeficiency Syndrome Market Share by Region (2021-2032) Figure 7. North America Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Image Figure 13. Global Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Image Figure 15. Global Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Acquired Immunodeficiency Syndrome Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Acquired Immunodeficiency Syndrome Market Share by Type 2025 VS 2032 Figure 18. North America Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2032) Figure 19. Europe Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2032) Figure 21. Latin America Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2032) Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Acquired Immunodeficiency Syndrome Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Acquired Immunodeficiency Syndrome Market Share by Application 2025 VS 2032 Figure 31. North America Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2032) Figure 32. Europe Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2032) Figure 34. Latin America Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Acquired Immunodeficiency Syndrome Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Acquired Immunodeficiency Syndrome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Acquired Immunodeficiency Syndrome Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 41. Europe Acquired Immunodeficiency Syndrome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Acquired Immunodeficiency Syndrome Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 44. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 47. Latin America Acquired Immunodeficiency Syndrome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Acquired Immunodeficiency Syndrome Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 50. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  • Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • Takeda
  • Sanofi
  • Novartis
  • Pfizer
  • Amgen
  • Merck KGaA
  • Daiichi Sankyo Company
  • Biogen
  • AstraZeneca Eli Lilly and Company
  • Actelion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Acquired Immunodeficiency Syndrome Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Acquired Immunodeficiency Syndrome Market Size by Region (2021-2032)
  5. 1.4.1 Global Acquired Immunodeficiency Syndrome Market Size by Region (2021-2026)
  6. 1.4.2 Global Acquired Immunodeficiency Syndrome Market Size by Region (2027-2032)
  7. 1.5 Key Regions Acquired Immunodeficiency Syndrome Market Size (2021-2032)
  8. 1.5.1 North America Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate (2021-2032)
2 Acquired Immunodeficiency Syndrome Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  3. 2.1.2 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  4. 2.2 Global Acquired Immunodeficiency Syndrome Market Size by Type
  5. 2.2.1 Global Acquired Immunodeficiency Syndrome Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Acquired Immunodeficiency Syndrome Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Acquired Immunodeficiency Syndrome Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Acquired Immunodeficiency Syndrome Market Size by Regions
  9. 2.3.1 North America Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Breakdown by Type (2021-2026)
3 Acquired Immunodeficiency Syndrome Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacy
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Others
  5. 3.2 Global Acquired Immunodeficiency Syndrome Market Size by Application
  6. 3.2.1 Global Acquired Immunodeficiency Syndrome Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Acquired Immunodeficiency Syndrome Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Acquired Immunodeficiency Syndrome Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Acquired Immunodeficiency Syndrome Market Size by Regions
  10. 3.3.1 North America Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Acquired Immunodeficiency Syndrome Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Acquired Immunodeficiency Syndrome Industry Trends
  2. 4.2 Acquired Immunodeficiency Syndrome Industry Drivers
  3. 4.3 Acquired Immunodeficiency Syndrome Industry Opportunities and Challenges
  4. 4.4 Acquired Immunodeficiency Syndrome Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Acquired Immunodeficiency Syndrome Revenue (2021-2026)
  2. 5.2 Global Acquired Immunodeficiency Syndrome Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Acquired Immunodeficiency Syndrome Key Company Headquarters & Area Served
  4. 5.4 Global Acquired Immunodeficiency Syndrome Company, Product Type & Application
  5. 5.5 Global Acquired Immunodeficiency Syndrome Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Acquired Immunodeficiency Syndrome Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Acquired Immunodeficiency Syndrome Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Acquired Immunodeficiency Syndrome Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Acquired Immunodeficiency Syndrome Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Acquired Immunodeficiency Syndrome Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Acquired Immunodeficiency Syndrome Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Acquired Immunodeficiency Syndrome Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Acquired Immunodeficiency Syndrome Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 Merck KGaA
  32. 6.6.1 Merck KGaA Company Information
  33. 6.6.2 Merck KGaA Business Overview
  34. 6.6.3 Merck KGaA Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck KGaA Acquired Immunodeficiency Syndrome Product Portfolio
  36. 6.6.5 Merck KGaA Recent Developments
  37. 6.7 Daiichi Sankyo Company
  38. 6.7.1 Daiichi Sankyo Company Company Information
  39. 6.7.2 Daiichi Sankyo Company Business Overview
  40. 6.7.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Portfolio
  42. 6.7.5 Daiichi Sankyo Company Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biogen Acquired Immunodeficiency Syndrome Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 AstraZeneca Eli Lilly and Company
  50. 6.9.1 AstraZeneca Eli Lilly and Company Company Information
  51. 6.9.2 AstraZeneca Eli Lilly and Company Business Overview
  52. 6.9.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Portfolio
  54. 6.9.5 AstraZeneca Eli Lilly and Company Recent Developments
  55. 6.10 Actelion
  56. 6.10.1 Actelion Company Information
  57. 6.10.2 Actelion Business Overview
  58. 6.10.3 Actelion Acquired Immunodeficiency Syndrome Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Actelion Acquired Immunodeficiency Syndrome Product Portfolio
  60. 6.10.5 Actelion Recent Developments
7 North America
  1. 7.1 North America Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  3. 7.3 North America Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  3. 8.3 Europe Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  3. 10.3 South America Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst